The global dry powder inhaler market is expected to top US$ 1.3 Bn by 2031, rising at a CAGR of 7.2% through 2021-2031. The market is estimated to create an absolute $ opportunity of about US$ 458 Mn by 2031. Currently, dry powder inhaler sales account for more than 35% of the global inhaler market.
The dry powder inhaler device market is anticipated to expand significantly due to the rise in respiratory disorders such asthma, chronic obstructive pulmonary disease (COPD), emphysema, and bronchitis. The increased use of dry powder inhalers (DPI) around the world is largely due to rising respiratory disorders like asthma and chronic obstructive pulmonary disease, an increase in per capita healthcare spending, and rising air pollution levels, particularly in developing nations.
For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7083
The readability score of the Dry Powder Inhaler Demand report is good as it offers chapter-wise layout with each section divided into a smaller sections.
The report encompasses graphs and tables to show the entire assembling. Pictorial demonstration of the definite and estimated values of key segments is visually appealing to readers.
This Dry Powder Inhaler outlook report explicates on vital dynamics such as the drivers, restraints and opportunities for key players and competitive analysis of Dry Powder Inhaler along with key stakeholders as well as emerging players associated with the manufacturing of product.
Competitive Landscape:
The global market for dry powder inhaling devices is a fragmented one, imputing to the existence of many domestic and regional players. Mergers, expansion, acquisitions, and partnerships of companies, along with new product development as strategic approaches are being adopted by leading companies to upscale their market presence and create a large customer base.
- For instance, Lonza, a chemicals and biotechnology solutions firm, lately launched a Center of Excellence for Dry Powder Inhaler (DPI) drug product development at its existing site in Bend, OR, where the company will use its expertise in particle engineering to help customers create and evaluate formulations.
Impact of COVID-19
A huge impact of the pandemic has been seen across different industries in the world. This impact has shaken the economy and caused a disturbance in the equilibrium.
The spread of coronavirus has been proved lethal for many across the globe. This pandemic has given way to several breathing concerns and respiratory issues that are more harmful for people already suffering from asthma, which is expected to increase demand for dry powder inhalers.
Also, breathlessness or shortness of breath is a common symptom among patients infected with COVID-19. This is likely to contribute to increasing sales of dry powder inhalers over the coming months and years.
Key Segments Covered:
· By Product Type
- Capsule-based Devices
- Blister-based Devices
- Reservoir/Cartridge-based Devices
- Others
· By Application
- Bronchitis
- Chronic Obstructive Pulmonary Diseases (COPD)
- Asthma
- Others
· By Sales Channel
- Offline Channels
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Other Sales Channels
- Online Channels
· By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East Africa
For in-depth competitive analysis, Buy Now:
https://www.factmr.com/checkout/7083
Questionnaire answered in the Market outlook Report of Dry Powder Inhaler include:
- What is the key strategy deployed by large players to maximize Dry Powder Inhaler growth?
- What are the main challenges faced by players in the Dry Powder Inhaler Demand?
- With the advent of technological advancement, how will the Dry Powder Inhaler landscape change over the forecast period?
- What does player bring to the table which is unique as a strategy, and is easy to emulate for new investors in the Dry Powder Inhaler size?
Contact:
US sales Office :
Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: [email protected]